Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CRNX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in CRINETICS PHARMACEUTICALS IN
VANGUARD CAPITAL MANAGEMENT LLC holds 4.7M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $177.6M as of 2026-Q2. The position was increased (+1.5% shares). CRNX represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$177.6M
Current Shares
4.7M
Total Value Change
+$7.8M
Total Shares Change
+71,327
Quarter-by-Quarter History
Other major holders of CRNX: FMR LLC